Visualitzant - Articles científics per títol

Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis

Osaba, Lourdes; Czischke, Karen; Jardim, José R; Fernandez Acquier, Mariano; Ali, Abraham; Miravitlles Fernández, Marc; López-Campos Bodineau, José Luis (BMC, 2022-06-10)

Fertility-Sparing Surgery versus Radical Hysterectomy in Early Cervical Cancer: A Propensity Score Matching Analysis and Noninferiority Study

Llueca, Antoni; Ibáñez Gual, Maria Victoria; Torne, Aureli; Gil Moreno, Antonio; Martin-Jimenez, Angel; Díaz-Feijoo, Berta (MDPI, 2022-06-30)

Fetal abdominal cysts: Predicting adverse outcomes

RODO, CARLOTA; Arévalo Martínez, Silvia; Molino Gahete, José Andrés; Garcia-Aguilar, Paula; Maiz, Nerea; Garcia-Manau, Pablo; Guillén Burrieza, Gabriela; Carreras, Elena (Wiley, 2023-07)

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

Bekaii-Saab, Tanios S; Valle, Juan W; Van Cutsem, Eric; Rimassa, Lorenza; Furuse, Junji; Ioka, Tatsuya; Macarulla Mercadé, Teresa (Future Medicine, 2020-10)

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC

Nishio, Makoto; Felip Font, Enriqueta; Orlov, Sergey; Park, Keunchil; Yu, Chong-Jen; Tsai, Chun-Ming (Elsevier, 2020-04)

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

Yoshino, Takayuki; Di Bartolomeo, Maria; Raghav, Kanwal; Masuishi, Toshiki; Loupakis, Fotios; Kawakami, Hisato; Elez, Elena (Nature Portfolio, 2023-06-07)

Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma

Bonvalot, Sylvie; Thariat, Juliette; Carrère, Sébastien; Ducassou, Anne; Sunyach, Marie-Pierre; Vergés Capdevila, Ramona; Rutkowski, Piotr (Elsevier, 2022-11-01)

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study

Tewari, Krishnansu S.; Sill, Michael W.; Birrer, Michael J.; Penson, Richard; Huang, Helen; Moore, David H.; Oaknin Benzaquen, Ana Mazaltob (Elsevier, 2023-04)

Financing and Reimbursement of Approved Advanced Therapies in Several European Countries

Iglesias-Lopez, Carolina; Agustí, Antònia; Vallano, Antonio; Obach, Mercè (Elsevier, 2023-06)

Finding MYCure

Beaulieu, Marie-Eve; Soucek, Laura (Taylor and Francis, 2019-06-20)

Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease

González Juanatey, José Ramón; Facila Rubio, Lorenzo; Valle, Alfonso; Gorriz, Jose Luis; Soler, María José; Ortiz Arduan, Alberto (Elsevier, 2023-07)

First field and laboratory evaluation of LAMP assay for malaria diagnosis in Cubal, Angola

Febrer Sendra, Begoña; Crego Vicente, Beatriz; Nindia, Arlette; Martínez-Campreciós, Joan; Aixut, Sandra; Mediavilla, Alejandro; Silgado, Aroa; Oliveira Souto, Inés; Salvador Velez, Fernando; Molina Romero, Israel; Sulleiro, Elena (BMC, 2023-10-03)

First field study using Strong-LAMP for diagnosis of strongyloidiasis in Cubal, Angola

Nindia, Arlette; Pessela, Agostinho; Aixut, Sandra; Mediavilla Pérez, Alejandro; Salvador Velez, Fernando M; Crego Vicente, Beatriz; Febrer Sendra, Begoña; Martínez-Campreciós, Joan; Silgado, Aroa; Sulleiro, Elena; Treviño Maruri, Begoña; Molina Romero, Israel (BMC, 2023-10-31)

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study

Pernas, Sonia; Villagrasa, Patricia; Vivancos Prellezo, Ana; Scaltriti, Maurizio; Rodon Ahnert, Jordi; Burgués, Octavio; Nuciforo, Paolo Giovanni; Antunes de Melo Oliveira, Ana Mafalda (Frontiers Media, 2021-11-04)

First universal newborn screening program for severe combined immunodeficiency in Europe: two-years' experience in Catalonia (Spain)

Argudo-Ramírez, Ana; Martín Nalda, Andrea; Pajares Garcia, Sonia; García Prat, Marina; Colobran Oriol, Roger; Rivière, Jacques; Soler Palacín, Pere; Marin Soria, José Luis; Lopez Galera, Rosa Maria; González de Aledo Castillo, José Manuel; Martínez Gallo, Mónica (Frontiers Media, 2019-10-22)

First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer

Yap, Timothy A.; Vieito Villar, Maria; Baldini, Capucine; Sepúlveda, Juan Manuel; Kondo, Shunsuke; Simonelli, Matteo (American Association for Cancer Research, 2021-12)

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

Salamero García, Olga; Willekens, Christophe; Pérez-Simón, José Antonio; Pigneux, Arnaud; Récher, Christian; Carpio Segura, Cecilia Carmen; Bosch Albareda, Francesc; Montesinos, Pau (American Society of Clinical Oncology, 2020-12-20)

First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas

Piha-Paul, Sarina; Geva, Ravit; Tan, Tira; Lim, Darren Wan-Teck; Hierro Carbó, Cinta; Doi, Toshikiko (BMJ, 2021-08)

First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia

Boyiadzis, Michael; Desai, Pinkal; Daskalakis, Nikki; Donnellan, William; Ferrante, Lucille; Goldberg, Jenna D.; Salamero García, Olga (Wiley, 2023-03)

First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome

Narayan, Rupa; Alfonso-Piérola, Ana; Donnellan, William; Abdul-Hay, Maher; Molero , Antonieta; Platzbecker, Uwe (Wiley, 2024-03-18)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant HVH - Articles científics per títol

Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis

Fertility-Sparing Surgery versus Radical Hysterectomy in Early Cervical Cancer: A Propensity Score Matching Analysis and Noninferiority Study

Fetal abdominal cysts: Predicting adverse outcomes

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study

Financing and Reimbursement of Approved Advanced Therapies in Several European Countries

Finding MYCure

Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease

First field and laboratory evaluation of LAMP assay for malaria diagnosis in Cubal, Angola

First field study using Strong-LAMP for diagnosis of strongyloidiasis in Cubal, Angola

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study

First universal newborn screening program for severe combined immunodeficiency in Europe: two-years' experience in Catalonia (Spain)

First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas

First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia

First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant HVH - Articles científics per títol

Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis ﻿

Fertility-Sparing Surgery versus Radical Hysterectomy in Early Cervical Cancer: A Propensity Score Matching Analysis and Noninferiority Study ﻿

Fetal abdominal cysts: Predicting adverse outcomes ﻿

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements ﻿

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC ﻿

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer ﻿

Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma ﻿

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study ﻿

Financing and Reimbursement of Approved Advanced Therapies in Several European Countries ﻿

Finding MYCure ﻿

Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease ﻿

First field and laboratory evaluation of LAMP assay for malaria diagnosis in Cubal, Angola ﻿

First field study using Strong-LAMP for diagnosis of strongyloidiasis in Cubal, Angola ﻿

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study ﻿

First universal newborn screening program for severe combined immunodeficiency in Europe: two-years' experience in Catalonia (Spain) ﻿

First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer ﻿

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia ﻿

First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas ﻿

First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia ﻿

First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis

Fertility-Sparing Surgery versus Radical Hysterectomy in Early Cervical Cancer: A Propensity Score Matching Analysis and Noninferiority Study

Fetal abdominal cysts: Predicting adverse outcomes

FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer

Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study

Financing and Reimbursement of Approved Advanced Therapies in Several European Countries

Finding MYCure

Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease

First field and laboratory evaluation of LAMP assay for malaria diagnosis in Cubal, Angola

First field study using Strong-LAMP for diagnosis of strongyloidiasis in Cubal, Angola

First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study

First universal newborn screening program for severe combined immunodeficiency in Europe: two-years' experience in Catalonia (Spain)

First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas

First-in-human study of JNJ-63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia

First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome